Corcept Therapeutics Incorporated
NASDAQCORT cost to borrow surges 184% in one week to 0.40%, signaling rising short pressure despite minimal short interest at 8.1% of float.
Snapshot as of 11 Jul 2026
Corcept Therapeutics has shifted gear: the stock is up 18% on the week and 38% over the past month, and this time the shorts are finally moving with it. The most meaningful change since last week's note is in short…
Corcept Therapeutics is climbing hard while short sellers refuse to blink — the stock has gained 31% in a month, yet short interest barely budged. Options traders have flipped from defensive to outright bullish in a…
Corcept Therapeutics enters the week after a strong earnings beat with shorts beating a steady retreat — and a high-profile analyst upgrade arriving just as the stock consolidates those gains. The setup is a study in…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CORT — free to start on ORTEX.
Sign up for free →Open CORT on ORTEX